Acadian Asset Management LLC cut its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV – Free Report) by 16.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 214,018 shares of the company’s stock after selling 40,998 shares during the period. Acadian Asset Management LLC owned approximately 0.77% of ZimVie worth $2,309,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the company. AlphaQuest LLC raised its stake in shares of ZimVie by 2,695.9% in the first quarter. AlphaQuest LLC now owns 8,947 shares of the company’s stock worth $97,000 after buying an additional 8,627 shares during the period. Quantbot Technologies LP purchased a new position in ZimVie during the 1st quarter valued at approximately $98,000. Jones Financial Companies Lllp grew its holdings in ZimVie by 9,039.1% during the 1st quarter. Jones Financial Companies Lllp now owns 12,612 shares of the company’s stock valued at $136,000 after buying an additional 12,474 shares in the last quarter. Hsbc Holdings PLC purchased a new position in ZimVie during the 1st quarter valued at approximately $144,000. Finally, State of Wyoming boosted its holdings in shares of ZimVie by 132.2% in the 1st quarter. State of Wyoming now owns 16,318 shares of the company’s stock worth $176,000 after purchasing an additional 9,291 shares during the period. Institutional investors own 95.63% of the company’s stock.
ZimVie Trading Up 0.1%
ZIMV opened at $18.89 on Tuesday. ZimVie Inc. has a 12 month low of $8.15 and a 12 month high of $19.01. The stock has a fifty day moving average price of $17.09 and a 200-day moving average price of $12.37. The company has a current ratio of 2.37, a quick ratio of 1.60 and a debt-to-equity ratio of 0.56. The firm has a market cap of $532.89 million, a price-to-earnings ratio of -26.99 and a beta of 2.20.
Analysts Set New Price Targets
A number of brokerages have recently commented on ZIMV. B. Riley cut ZimVie from a “buy” rating to a “neutral” rating and set a $19.00 target price for the company. in a report on Thursday, July 31st. Barclays raised ZimVie from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $9.00 to $19.00 in a research note on Tuesday, July 22nd. Finally, Wall Street Zen lowered ZimVie from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 18th. Four investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $17.75.
Get Our Latest Analysis on ZIMV
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Recommended Stories
- Five stocks we like better than ZimVie
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Reddit Hits Record Highs: Why Wall Street Is Taking Notice
- 3 Stocks to Consider Buying in October
- After a Strong Wall Street Debut, Klarna’s Real Work Begins
- Insider Trading – What You Need to Know
- 3 Dividend Growers That Fly Under the Radar
Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMV – Free Report).
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.